Differences in Immunological Landscape between EGFR-Mutated and Wild-Type Lung AdenocarcinomaCaicun Zhou(Shanghai Pulmonary Hospital)Disease MarkersAugust 26, 202110.1155/2021/3776854Cited by 6SaveCiteExport RISWatch citationsRelated Papers<p>Expression of PD-1 and PD-L1 on Tumor-Infiltrating Lymphocytes Predicts Prognosis in Patients with Small-Cell Lung Cancer</p>|OncoTargets and Therapy|2020|44Mechanisms of Progression and Heterogeneity in Multiple Nodules of Lung Adenocarcinoma|Small Methods|2021|18